Investor Presentation slide image

Investor Presentation

20 20 Investor presentation First six months of 2022 Appendix Novo Nordisk corporate strategy Diabetes care GLP-1 Insulin Obesity care 21 32 42 49 57 Rare disease 75 Other serious chronic diseases 86 Regional information 104 Financials 138 Sustainability 147
View entire presentation